Highlights
Profile claimed by owner
About
Bacteria-based Immunotherapy Treatment
Baccine is a pre-clinical biotechnology company bringing innovative proprietary bacteria-based cancer vaccines to provide new hope for cancer patients. The company’s innovative multi-acting approach aims to provide efficient immunotherapy treatments with increased response rates and reduced side effects via localized action. Baccine was established together with the Weizmann Institute of Science, following years of research focusing on cancer resistance mechanisms, the tumor microenvironment, and the role of bacteria in tumors.
Identity
| Name | Baccine |
|---|---|
| Slug | baccine |
| Type / kind | startup |
| Source _id | NnZvdFlWyUmCV9JVlMcnoy2oqQLCBEtZFPUiRRhZjETEzQx1QjsNdV |
Status
| Status | active |
|---|---|
| Last update | 2026-05-17 |
Location
| HQ country code | IL |
|---|---|
| HQ region/district | Center District |
| HQ city | Rehovot |
| HQ address | Prof. Hillel ve-Khanan Oppenheimer St 2, Rehovot, Israel |
Web & social
| Website | https://baccine.tech |
|---|---|
| https://www.linkedin.com/company/82659953 |
Classifications
Primary sector Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyBiomaterials & Tissue Engineering
Target customers
Healthcare & Life SciencesHealthcarePatientsLife SciencesPharmaceuticalsBiotechnology
Business models
B2C
Tags
cancer-therapycancercancer-research
Funding
| Total raised | — |
|---|---|
| Current stage | Seed |
Raw source document
Show full JSON (0 KB)
{
"0": "s",
"1": "l",
"2": "i",
"3": "m",
"4": "p",
"5": "a",
"6": "g",
"7": "e",
"8": "s",
"9": "_",
"10": "i",
"11": "m",
"12": "p",
"13": "o",
"14": "r",
"15": "t"
}